Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Normal saline versus hydroxyethyl starch graft flush before reperfusion in liver transplantation
IRCT20121204011662N18Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Normal Saline-Benha University and hetastarch in liver transplant (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Postoperative graft function and Post-reperfusion syndrome. Started Aug 2025; status: completed.
02
Drugs
Normal Saline-Benha Universityhetastarch
03
Conditions
liver transplant
Beyond the preview
Go deeper on IRCT20121204011662N18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20121204011662N18.